Markets.com Logo

BIVI

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    1.5445$
  • Previous Close
    1.5124$
  • 52 Week Change
    43.34$
  • Day Range
    0.03$
  • 52 Week High/Low
    1.46$ - 44.8$
  • Dividend Per Share
    --
  • Market cap
    11 664 K$
  • EPS
    -1.88
  • Beta
    1.068
  • Volume
    --

About

BIVI.US represents BioVie Inc., a biopharmaceutical company focused on developing innovative drug therapies for neurodegenerative and neurological disorders. The company's lead product candidate, NE3107, is an oral small molecule being developed for the treatment of Alzheimer's disease and other neuroinflammatory conditions. BioVie is conducting clinical trials to evaluate the safety and efficacy of NE3107 and other potential therapies.
Top 3 tech stocks to buy in 2026: Nebius (NBIS), MSTR stock, AAPL stock

Top 3 tech stocks to buy in 2026: Nebius (NBIS), MSTR stock, AAPL stock

Ghko B|--
BitGo crypto IPO: BitGo (BTGO) stock soars 20%, is BitGo a good buy?

BitGo crypto IPO: BitGo (BTGO) stock soars 20%, is BitGo a good buy?

Ghko B|--
Gold hits a new record above $4800: What is gold price prediction for 2026?

Gold hits a new record above $4800: What is gold price prediction for 2026?

Frances Wang|--
Trending tech stocks analysis: Intel stock jumps 12%, NVDA shares up 3%

Trending tech stocks analysis: Intel stock jumps 12%, NVDA shares up 3%

Frances Wang|--
Forex CFD trading platform reviews 2026: markets.com, IG, Avatrade

Forex CFD trading platform reviews 2026: markets.com, IG, Avatrade

Ghko B|--
ARK 21shares Bitcoin ETF (ARKB) analysis: Is ARKB a good investment?

ARK 21shares Bitcoin ETF (ARKB) analysis: Is ARKB a good investment?

Ghko B|--
EV stocks today: TSLA is going down, Lucid (LCID) stock rises, RIVN drops

EV stocks today: TSLA is going down, Lucid (LCID) stock rises, RIVN drops

Ghko B|--

Factors

Please include at least 3 factors. Clinical Trial Results: Positive outcomes in clinical trials for BIVI.US's drug candidates significantly boost investor confidence, driving up stock prices. Conversely, negative or inconclusive results can lead to a sharp decline.

Regulatory Approvals: Receipt of regulatory approvals from bodies like the FDA for BIVI.US's products is a major catalyst, signaling market access and potential revenue generation. Delays or rejections negatively impact stock value.

Market Sentiment: Overall investor sentiment towards the biotechnology sector, influenced by economic conditions, geopolitical events, and broader market trends, affects BIVI.US. A positive market environment usually benefits the stock, while negative sentiment can pressure it downwards.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--
Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--
Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

Crypto day trading: How to day trade crypto CFDs with markets.com?

Crypto day trading: How to day trade crypto CFDs with markets.com?

Ghko B|--
Leverage trading: Difference between margin calls and forced liquidation

Leverage trading: Difference between margin calls and forced liquidation

Ghko B|--
Futures CFDs trading: What is futures trading, how to trade futures?

Futures CFDs trading: What is futures trading, how to trade futures?

Ghko B|--